The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritis
Abstract
This review has summarized information published over the last 5 years on the presence and pathophysiologic role of IL-1 and TNF alpha in RA. The evidence to date shows that 5 of 6 criteria for identifying mediators of tissue damage in human autoimmune diseases are satisfied (Table 1). The last criterion, prevention of clinical progression in patients with RA, is currently being evaluated. Many new therapeutic approaches are currently being developed, including the use of soluble receptors to IL-1 or TNF, monoclonal antibodies to TNF alpha, a specific IL-1 receptor antagonist, and gene therapy with the latter molecule. It should be emphasized that both IL-1 and TNF alpha play important roles in normal host defense; the possible complications of blocking their production or effects need to be carefully evaluated in long-term studies. A recent review has emphasized that although IL-1 and TNF alpha have many overlapping biologic properties, each may exhibit distinct effects in joint disease (99). Anti-TNF treatment may be primarily antiinflammatory but blocking IL-1 may be more effective in preventing cartilage destruction (100). The possibility exists that simultaneous inhibition of TNF alpha and IL-1 may be more therapeutically efficacious than blockade of either agent alone, as was recently demonstrated with IL-1ra and soluble TNF receptors in bacterial cell wall-induced arthritis in rats (101). The next level of clinical studies in rheumatoid arthritis should include the use of two biologic response modifiers together, or one agent combined with a more traditional form of therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,660
Sampaio, E. P., Sarno, E. N., Galilly, R., Cohn, Z. A., & Kaplan, G. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.699 · Cited by 1,192
BRENNAN, F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90430-3 · Cited by 1,129
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
Elliott, M. J., Maini, R. N., Feldmann, M., Long‐Fox, A., Charles, P., Katsikis, P., Brennan, F. M., Walker, J., Bijl, H., Ghrayeb, J., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780361206 · Cited by 1,038
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams, R. O., Feldmann, M., & Maini, R. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9784 · Cited by 989
Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis
Arend, W. P., & Dayer, J. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330302 · Cited by 949
Self-citationStabilization of the bioactivity of tumor necrosis factor by its soluble receptors.
Aderka, D., Engelmann, H., Maor, Y., Brakebusch, C., & Wallach, D. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.2.323 · Cited by 814
Elevated cerebrospinal fluid levels of substance p in patients with the fibromyalgia syndrome
Russell, I. J., Orr, M. D., Littman, B., Vipraio, G. A., Alboukrek, D., Michalek, J. E., Lopez, Y., & Mackillip, F. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371106 · Cited by 679
Interleukin-1 Receptor Antagonist
Arend, W. P. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60535-0 · Cited by 671
Self-citationQuantitative analysis of cytokine gene expression in rheumatoid arthritis.
Firestein, G. S., Alvaro-Gracia, J. M., & Maki, R. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.9.3347 · Cited by 598
Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.
Arend, W. P., Welgus, H. G., Thompson, R. C., & Eisenberg, S. P. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114622 · Cited by 581
Self-citationChu, C. Q., Field, M., Feldmann, M., & Maini, R. N. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340908 · Cited by 578
TNFα—A PIVOTAL ROLE IN RHEUMATOID ARTHRITIS?
BRENNAN, F. M., MAINI, R. N., & FELDMANN, M. (1992) · Rheumatology · doi:10.1093/rheumatology/31.5.293 · Cited by 386
Thorbecke, G. J., Shah, R., Leu, C. H., Kuruvilla, A. P., Hardison, A. M., & Palladino, M. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7375 · Cited by 360
Cope, A. P., Gibbons, D., Brennan, F. M., Feldmann, M., Aderka, D., Doherty, M., Jones, A. C., Engelmann, H., Wallach, D., & Maini, R. N. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780351008 · Cited by 337
Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis.
Farahat, M. N., Yanni, G., Poston, R., & Panayi, G. S. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.12.870 · Cited by 319
Haworth, C., Brennan, F. M., Chantry, D., Turner, M., Maini, R. N., & Feldmann, M. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211039 · Cited by 299
Wooley, P. H., Dutcher, J., Widmer, M. B., & Gillis, S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.11.6602 · Cited by 293
Bandara, G., Mueller, G. M., Galea-Lauri, J., Tindal, M. H., Georgescu, H. I., Suchanek, M. K., Hung, G. L., Glorioso, J. C., Robbins, P. D., & Evans, C. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10764 · Cited by 290
Inactivation of Interleukin-1.beta. Converting Enzyme by Peptide (Acyloxy)methyl Ketones
Thornberry, N. A., Peterson, E. P., Zhao, J. J., Howard, A. D., Griffin, P. R., & Chapman, K. T. (1994) · Biochemistry · doi:10.1021/bi00179a020 · Cited by 265
Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment
VAN DEN BERG, W. B., JOOSTEN, L. A. B., HELSEN, M., & VAN DE LOO, F. A. J. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06517.x · Cited by 251
Cope, A. P., Londei, M., Chu, N. R., Cohen, S. B., Elliott, M. J., Brennan, F. M., Maini, R. N., & Feldmann, M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117394 · Cited by 243
Piguet, P. F., Grau, G. E., Vesin, C., Loetscher, H., Gentz, R., & Lesslauer, W. (1992) · PubMed Central · Cited by 232
CHU, C. Q., FIELD, M., ALLARD, S., ABNEY, E., FELDMANN, M., & MAINI, R. N. (1992) · Rheumatology · doi:10.1093/rheumatology/31.10.653 · Cited by 229
Deleuran, B. W., Chu, C., Field, M., Brennan, F. M., Mitchell, T., Feldmann, M., & Maini, R. N. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780351009 · Cited by 217
Synovial interleukin‐1 receptor antagonist and interleukin‐1 balance in rheumatoid arthritis
Firestein, G. S., Boyle, D. L., Yu, C., Paine, M. M., Whisenand, T. D., Zvaifler, N. J., & Arend, W. P. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370507 · Cited by 210
Self-citationTetta, C., Camussi, G., Modena, V, Di Vittorio, C., & Baglioni, C. (1990) · Annals of the Rheumatic Diseases · doi:10.1136/ard.49.9.665 · Cited by 209
Wooley, P. H., Whalen, J. D., Chapman, D. L., Berger, A. E., Richard, K. A., Aspar, D. G., & Staite, N. D. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360915 · Cited by 204
Parmely, M. J., Zhou, W. W., Edwards, C. K., Borcherding, D. R., Silverstein, R., & Morrison, D. C. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.1.389 · Cited by 191
Adenoviral-mediated gene transfer to rabbit synovium in vivo.
Roessler, B. J., Allen, E. D., Wilson, J. M., Hartman, J. W., & Davidson, B. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116614 · Cited by 184
DELEURAN, B. W., CHU, C. Q., FIELD, M., BRENNAN, F. M., KATSIKIS, P., FELDMANN, M., & MAINI, R. N. (1992) · Rheumatology · doi:10.1093/rheumatology/31.12.801 · Cited by 183
Lacraz, S., Isler, P., Vey, E., Welgus, H. G., & Dayer, J. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31750-7 · Cited by 177
Self-citationKahle, P., Saal, J. G., Schaudt, K., Zacher, J., Fritz, P., & Pawelec, G. (1992) · Annals of the Rheumatic Diseases · doi:10.1136/ard.51.6.731 · Cited by 172
Purification and characterization of a novel soluble receptor for interleukin 1.
Symons, J. A., Eastgate, J. A., & Duff, G. W. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1251 · Cited by 171
Allen, J. B., Wong, H. L., Costa, G. L., Bienkowski, M. J., & Wahl, S. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.8.4344 · Cited by 168
Balance of synovial fluid IL-1β and IL-1 receptor antagonist and recovery from Lyme arthritis
Miller, L. C., Lynch, E. A., Isa, S., Dinarello, C. A., Logar, J. W., & Steere, A. C. (1993) · The Lancet · doi:10.1016/0140-6736(93)90006-3 · Cited by 164
Seckinger, P., Klein‐Nulend, J., Alander, C., Thompson, R. C., Dayer, J. M., & Raisz, L. G. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4181 · Cited by 154
Self-citationSchwab, J. H., Anderle, S. K., Brown, R. R., Dalldorf, F. G., & Thompson, R. C. (1991) · Infection and Immunity · doi:10.1128/iai.59.12.4436-4442.1991 · Cited by 152
van de Loo, A. A. J., & van den Berg, W. B. (1990) · Annals of the Rheumatic Diseases · doi:10.1136/ard.49.4.238 · Cited by 139
Firestein, G. S., Berger, A. E., Tracey, D. E., Chosay, J. G., Chapman, D. L., Paine, M. M., Yu, C., & Zvaifler, N. J. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.3.1054 · Cited by 131
Treatment of refractory rheumatoid arthritis with a chimeric ANTI‐CD4 monoclonal antibody
Moreland, L. W., Pratt, P. W., Bucy, R. P., Jackson, B. S., Feldman, J. W., & Koopman, W. J. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370610 · Cited by 115
Henderson, B. E., Thompson, R. C., Hardingham, T., & Lewthwaite, J. (1991) · Cytokine · doi:10.1016/1043-4666(91)90023-7 · Cited by 114
Smith, R. J., Chin, J. E., Sam, L. M., & Justen, J. M. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780340112 · Cited by 113
Zangerle, P. F., Groote, D. D., Lopez, M., Meuleman, R. J., Vrindts, Y., Fauchet, F., Dehart, I., Jadoul, M. Y., Radoux, D., & Franchimont, P. (1992) · Cytokine · doi:10.1016/1043-4666(92)90021-i · Cited by 111
Campbell, I. K., Piccoli, D. S., Roberts, M. J., Muirden, K. D., & Hamilton, J. A. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330412 · Cited by 105
Malyak, M., Swaney, R. E., & Arend, W. P. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360607 · Cited by 95
Self-citationvan de Loo, F. A. J., Arntz, O. J., Otterness, I. G., & van den Berg, W. B. (1992) · PubMed · Cited by 92
O’Byrne, E., Blancuzzi, V., Wilson, D. E., Wong, M., & Jeng, A. Y. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330715 · Cited by 91
Brennan, F. M., Gibbons, D. L., Cope, A. P., Feldmann, M., Mitchell, T. J., & Maini, R. N. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220734 · Cited by 91
The role of cytokines and their inhibitors in arthritis
Dayer, J., & Fenner, H. (1992) · Baillière s Clinical Rheumatology · doi:10.1016/s0950-3579(05)80186-4 · Cited by 78
Self-citationMatsukawa, A., Ohkawara, S., Maeda, T., Takagi, K., & Yoshinaga, M. (1993) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb07967.x · Cited by 74
Staite, N. D., Richard, K. A., Aspar, D. G., Franz, K. A., Galinet, L. A., & Dunn, C. J. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330215 · Cited by 72
Koch, A. E., Kunkel, S. L., Chensue, S. W., Haines, G. K., & Strieter, R. M. (1992) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(92)90243-h · Cited by 71
Mcdonnell, J., Hoerrner, L. A., Lark, M. W., Harper, C. F., Dey, T., Lobner, J. M., Eiermann, G. J., Kazazis, D. M., Singer, I. I., & Moore, V. L. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350714 · Cited by 66
Lewthwaite, J. C., Blake, S. M., Hardingham, T., Pj, W., & Henderson, B. E. (1994) · PubMed · Cited by 56
The effects of methotrexate on interleukin 1 in patients with rheumatoid arthritis.
Chang, D. M., Weinblatt, M. E., & Schur, P. H. (1992) · PubMed · Cited by 53
A soluble binding protein specific for interleukin 1β is produced by activated mononuclear cells
Symons, J. A., Eastgate, J. A., & Duff, G. W. (1990) · Cytokine · doi:10.1016/1043-4666(90)90015-l · Cited by 53
Goto, M., Fujisawa, M., Yamada, A., et al. (1990) · Annals of the Rheumatic Diseases · doi:10.1136/ard.49.3.172 · Cited by 51
Prospects for treating arthritis by gene therapy.
Evans, C. H., & Robbins, P. D. (1994) · PubMed · Cited by 49
Chikanza, I. C., Roux-Lombard, P., DAYER, J.-M., & Panayi, G. S. (1993) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05941.x · Cited by 47
Self-citationRuschen, S., Stellberg, W., & Warnatz, H. (1992) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1992.tb06873.x · Cited by 44
Yanni, G., Whelan, A. M., Feighery, C., Quinlan, W., Symons, J. A., Duff, G. W., & Bresnihan, B. (1993) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb08190.x · Cited by 36
Hom, J. T., Cole, H. W., Estridge, T. B., & Gliszczynski, V. L. (1992) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(92)90022-g · Cited by 34
New Directions for Biological Therapy in Rheumatoid Arthritis
Elliott, M. J., & Maini, R. N. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000236718 · Cited by 31
Zarco, P., Maestre, C., Herrero‐Beaumont, G., González, E. M., García-Hoyo, R., Navarro, F., Braquet, P. G., & Egido, J. (1992) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1992.tb03080.x · Cited by 23
The prospect for cytokine based therapeutic strategies in rheumatoid arthritis.
Campion, G. (1994) · Annals of the Rheumatic Diseases · doi:10.1136/ard.53.8.485 · Cited by 22
Smith, R. J., Justen, J. M., Ulrich, R. G., Lund, J. E., & Sam, L. M. (1992) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(92)90191-p · Cited by 14
For Debate: Criteria for Identifying Mediators of Tissue Damage in Human Autoimmune Diseases
Hollander, A. P. (1991) · Autoimmunity · doi:10.3109/08916939109006754 · Cited by 4
Cited by
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
Choy, E. H. S., & Panayi, G. S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103223441207 · Cited by 2,249
Klareskog, L., van der Heijde, D., de Jager, J. P., Gough, A., Kalden, J., Malaise, M., Mola, E. M., Pavelka, K., Sany, J., Settas, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15640-7 · Cited by 1,751
Moreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, E. A., Fleischmann, R. M., Weaver, A. L., Ettlinger, R. E., Cohen, S., Koopman, W. J., Mohler, K., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370301 · Cited by 1,622
Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
Feldmann, M., & Maini, R. N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.163 · Cited by 1,257
Neutrophils: Molecules, Functions and Pathophysiological Aspects
Witko-Sarsat, V., Rieu, P., Descamps-Latscha, B., Lesavre, P., & Halbwachs-Mecarelli, L. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780067 · Cited by 1,135
Metadata
- Authors
- Arend, W. P., & Dayer, J.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1995-02
- Volume
- 38
- Issue
- 2
- Pages
- 151-160
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2031670584
- Cited by
- 891
- References
- 68
- FWCI
- 43.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.